Radiotheranostics: a roadmap for future developmentKen Herrmann, Ralph Weissleder, Markus Schwaiger et al.|The Lancet Oncology|2020Cited by 306
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click ChemistryBrian M. Zeglis, Jason S. Lewis, Ralph Weissleder et al.|Journal of Nuclear Medicine|2013Cited by 301
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast CancerJessica J. Tao, Maurizio Scaltriti, Gregory Weitsman et al.|Science Signaling|2014Cited by 166
1-<sup>11</sup>C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate CancerAmy L. Vāvere, Jason S. Lewis|Journal of Nuclear Medicine|2008Cited by 154
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-TrastuzumabJason P. Holland, Jason S. Lewis|PLoS ONE|2010Cited by 129